Company registration number 06814180 (England and Wales)
AUTOLOGIC DIAGNOSTICS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
AUTOLOGIC DIAGNOSTICS LIMITED
COMPANY INFORMATION
Directors
Mr J L Brandt
Mr K J Finn
Mr L Geilen
Mr B Herron
Company number
06814180
Registered office
Unit 7
Wornal Park
Menmarsh Road
Worminghall
Buckinghamshire
United Kingdom
HP18 9PH
Auditor
Azets Audit Services
Suites B & D
Burnham Yard
London End
Beaconsfield
Buckinghamshire
United Kingdom
HP9 2JH
AUTOLOGIC DIAGNOSTICS LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 22
AUTOLOGIC DIAGNOSTICS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024.

Review of the business

The results for the year and financial position of the company are as shown in the annexed financial statements

 

Turnover for the year of £6,464,624 (2023: £6,533,499) was similar to the prior year. During 2024, we have appointed a new Distributor in Scandinavia which will assist us increasing sales in Europe in 2025.

 

During the year we continued to sell our Diagnostic Tools, DrivePRO and FixPRO and our newly launched DrivePRO 2 tool will drive future sales. Our aftersales Diagnostic Support Subscription service continues to be important to our customer base. In addition, our Remote Services operation continues to grow, with more customers now relying on this service, offered as a Pay as you Go service. Going forward we intend to continue enhancing the automation of this service as much as possible, as well as the range of Technology used.

Principal risks and uncertainties

The principal risks to the business are mainly related to the speed of technological change and legislative changes in the Global Automotive industry. We are mitigating this risk by ongoing product development within Opus IVS Global Division and an on-going involvement in a number of Automotive bodies.

 

Key uncertainties reside around our competitors’ technological capabilities and price points, which could provide them with competitive advantage. This continues to be monitored by the management team.

Key performance indicators

The key financial indicators used by management to monitor company performance are:

 

Diagnostic Support Subscription and services growth, 2024 revenue £5,013,994 compared to 2023 revenue £4,944,000.

 

Operating Profit before taxation growth, 2024 £392,041 compared to 2023 £18,664 attributed to a reduction in overheads relating to office premises, headcount restructure and more efficiencies using technology.

 

On behalf of the board

 

 

 

Mr J L Brandt
Director
16 July 2025
AUTOLOGIC DIAGNOSTICS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company is the provision of vehicle diagnostics and technical support services and solutions to the independent automotive repair industry. The company also acts as a parent company and is part of a global division of Opus Group known as Opus IVS.

Results and dividends

The company is a wholly owned subsidiary of its Parent company, Autologic Diagnostics Holdings Limited (company number 07079844). The Parent company and all its subsidiaries are owned by Ograi TopCo AB, based in Sweden.

The results of the company for the year are set out in the profit and loss account. The operating profit for the year was £392,041 (2023: £18,664) and the profit for the year after taxation was £392,041 (2023: £68,196).

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr J L Brandt
Mr K J Finn
Mr L Geilen
Mr B Herron
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

 

 

 

On behalf of the board
Mr J L Brandt
Director
16 July 2025
AUTOLOGIC DIAGNOSTICS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

AUTOLOGIC DIAGNOSTICS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF AUTOLOGIC DIAGNOSTICS LIMITED
- 4 -
Opinion

We have audited the financial statements of Autologic Diagnostics Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

AUTOLOGIC DIAGNOSTICS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF AUTOLOGIC DIAGNOSTICS LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

AUTOLOGIC DIAGNOSTICS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF AUTOLOGIC DIAGNOSTICS LIMITED
- 6 -

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

 

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework.  Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion.  This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

 

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

 

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation.  This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.  The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

David Green MA (Cantab) FCA
Senior Statutory Auditor
For and on behalf of Azets Audit Services
31 July 2025
Chartered Accountants
Statutory Auditor
Suites B & D
Burnham Yard
London End
Beaconsfield
Buckinghamshire
United Kingdom
HP9 2JH
AUTOLOGIC DIAGNOSTICS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2024
2023
Notes
£
£
Turnover
3
6,464,625
6,533,499
Cost of sales
(3,139,354)
(2,937,686)
Gross profit
3,325,271
3,595,813
Administrative expenses
(2,933,230)
(3,577,149)
Operating profit
4
392,041
18,664
Interest receivable and similar income
-
0
1,348
Profit before taxation
392,041
20,012
Tax on profit
7
-
0
48,184
Profit for the financial year
392,041
68,196

The profit and loss account has been prepared on the basis that all operations are continuing operations.

AUTOLOGIC DIAGNOSTICS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
8
129,174
75,206
Investments
9
7,713,945
7,713,945
7,843,119
7,789,151
Current assets
Stocks
11
170,395
197,501
Debtors
12
1,678,122
1,415,545
Cash at bank and in hand
858,540
287,786
2,707,057
1,900,832
Creditors: amounts falling due within one year
13
(12,200,710)
(11,606,243)
Net current liabilities
(9,493,653)
(9,705,411)
Total assets less current liabilities
(1,650,534)
(1,916,260)
Creditors: amounts falling due after more than one year
14
(46,428)
(137,248)
Provisions for liabilities
Provisions
15
110,791
146,286
(110,791)
(146,286)
Net liabilities
(1,807,753)
(2,199,794)
Capital and reserves
Called up share capital
19
12,098
12,098
Share premium account
1,083,066
1,083,066
Profit and loss reserves
(2,902,917)
(3,294,958)
Total equity
(1,807,753)
(2,199,794)
The financial statements were approved by the board of directors and authorised for issue on 16 July 2025 and are signed on its behalf by:
Mr J L Brandt
Director
Company Registration No. 06814180
AUTOLOGIC DIAGNOSTICS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
Share capital
Share premium account
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2023
12,098
1,083,066
(3,363,154)
(2,267,990)
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
68,196
68,196
Balance at 31 December 2023
12,098
1,083,066
(3,294,958)
(2,199,794)
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
-
392,041
392,041
Balance at 31 December 2024
12,098
1,083,066
(2,902,917)
(1,807,753)
AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
1
Accounting policies
Company information

Autologic Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 7, Wornal Park, Menmarsh Road, Worminghall, Buckinghamshire, United Kingdom, HP18 9PH.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Ograi TopCo AB.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

 

Autologic Diagnostics Limited is a wholly owned subsidiary of Autologic Diagnostics Holdings Limited and the results of Autologic Diagnostics Limited are included in the consolidated financial statements of Ograi TopCo AB which are available from Opus Group, Ostra Hamngatan 16, 411 09 Gothenburg, Sweden.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Despite being in a net liability position, the company is profit making and the company's parent, Opus Group AB, has confirmed its willingness to support the company for a period of 12 months from the date of these financial statements. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -
1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually the point at which the customer has signed for the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Turnover relating to technical support contracts is credited to the profit and loss account over the period to which the contract relates.

 

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
straight line over life of leasehold
Fixtures and fittings
15% on reducing balance
Computers
straight line - 3 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are valued at the lower of cost and net realisable value. Cost is determined on a standard cost basis but without any addition of indirect overheads. Net realisable value represents estimated selling price less costs to complete and sell.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
1.12
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

Warranty Provision

Provisions are made when recognising revenue to cover expected sales returns, claims and remedial costs under sales warranties. These provisions are based on an assessment of future claims with reference to past experience. Such costs are generally incurred within 2 years following delivery.

 

Dilapidations provision

Provisions are made to cover the costs of potential dilapidations from leased property occupied by the company on termination of leases. These provisions are built up over the period of the lease where deemed necessary and are reviewed annually to assess their adequacy.

1.13
Retirement benefits

A defined contribution plan is a post-employment benefit plan under which the company pays fixed contributions into a separate entity and will have no legal or constructive obligation to pay further amounts. Obligations for contributions to defined contribution pension plans are recognised as an expense in the profit and loss account in the periods during which services are rendered by employees.

1.14
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Sales of goods
1,450,631
1,589,499
Sales of services
5,013,994
4,944,000
6,464,625
6,533,499
AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
3
Turnover and other revenue
(Continued)
- 16 -
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
5,314,610
4,830,397
Europe
554,958
982,384
Rest of world
595,057
720,718
6,464,625
6,533,499
2024
2023
£
£
Other revenue
Interest income
-
1,348
4
Operating profit
2024
2023
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange gains
(3,152)
(67,682)
Fees payable to the company's auditor for the audit of the company's financial statements
37,000
35,800
Depreciation of owned tangible fixed assets
56,361
53,777
Loss on disposal of tangible fixed assets
173
-
Cost of stocks recognised as an expense
1,315,291
1,810,923
Operating lease charges
169,919
254,237
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Technical
53
56
Non-technical
13
14
Total
66
70
AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Employees
(Continued)
- 17 -

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
3,196,848
3,338,886
Social security costs
365,692
387,763
Pension costs
158,183
176,360
3,720,723
3,903,009
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
-
0
165,524
Company pension contributions to defined contribution schemes
-
54,254
-
0
219,778

 

7
Taxation
2024
2023
£
£
Current tax
Adjustments in respect of prior periods
-
0
(48,184)

From 1 April 2023, there is no longer a single Corporation Tax rate for non-ring fence profits. At the Spring Budget 2021, the government announced that the Corporation Tax main rate for non-ring fence profits would increase to 25% for profits above £250,000. A small profits rate of 19% was also announced for companies with profits of £50,000 or less. Companies with profits between £50,000 and £250,000 will pay tax at the main rate, reduced by a marginal relief.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
7
Taxation
(Continued)
- 18 -

The actual charge/(credit) for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
392,041
20,012
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 25.00%)
98,010
5,003
Tax effect of expenses that are not deductible in determining taxable profit
3,337
626
Unutilised tax losses carried forward
(110,276)
11,305
Permanent capital allowances in excess of depreciation
-
0
(16,934)
Refunds in respect of prior years
-
0
(48,184)
Adjustments to brought forward values
8,929
-
0
Taxation charge/(credit) for the year
-
(48,184)
8
Tangible fixed assets
Leasehold land and buildings
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 January 2024
92,301
100,941
186,516
379,758
Additions
46,977
15,138
56,338
118,453
Disposals
(92,301)
(43,843)
(67,965)
(204,109)
At 31 December 2024
46,977
72,236
174,889
294,102
Depreciation and impairment
At 1 January 2024
91,430
78,737
134,385
304,552
Depreciation charged in the year
11,310
6,985
38,066
56,361
Eliminated in respect of disposals
(92,300)
(35,720)
(67,965)
(195,985)
At 31 December 2024
10,440
50,002
104,486
164,928
Carrying amount
At 31 December 2024
36,537
22,234
70,403
129,174
At 31 December 2023
871
22,204
52,131
75,206
9
Fixed asset investments
2024
2023
Notes
£
£
Investments in subsidiaries
10
7,713,945
7,713,945
AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
10
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Autologic Diagnostics International Limited
Unit 7 Wornal Park, Menmarsh Road, Worminghall, Buckinghamshire, England, HP18 9PH
Ordinary
100.00
-
Diagnos Limited
Unit 7 Wornal Park, Menmarsh Road, Worminghall, Buckinghamshire, England, HP18 9PH
Ordinary
100.00
-
Opus IVS, Inc
7322 Newman Blvd., Building #3
Dexter, MI 48130, USA
Ordinary
0
100.00
Autologic Diagnostics Pty
Limited
Suite 2, Level 1, 58 Victor Crescent,
Narre Warren, Victoria,
3805, Australia
Ordinary
0
100.00
11
Stocks
2024
2023
£
£
Finished goods and goods for resale
170,395
197,501
12
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
196,180
73,558
Amounts owed by group undertakings
1,157,464
1,020,825
Prepayments and accrued income
248,072
244,756
1,601,716
1,339,139
2024
2023
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 16)
76,406
76,406
Total debtors
1,678,122
1,415,545

Amounts owed by group undertakings are interest free and repayable on demand.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 20 -
13
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Trade creditors
190,181
182,929
Amounts owed to group undertakings
10,879,451
10,262,461
Taxation and social security
276,885
240,064
Deferred income
17
560,167
491,664
Accruals and deferred income
294,026
429,125
12,200,710
11,606,243

Amounts owed to group undertakings are interest free and repayable on demand.

14
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Deferred income
17
46,428
137,248
15
Provisions for liabilities
2024
2023
£
£
Product Warranties
13,000
13,000
Dilapidations
97,791
133,286
110,791
146,286
Movements on provisions:
Product Warranties
Dilapidations
Total
£
£
£
At 1 January 2024
13,000
133,286
146,286
Utilisation of provision
-
(35,495)
(35,495)
At 31 December 2024
13,000
97,791
110,791

Dilapidations

 

The provision for dilapidations relates to expected dilapidations on leased property. It is expected that the majority of this expenditure will be incurred on expiry of the lease and that all will be incurred within a year of the balance sheet date.

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
15
Provisions for liabilities
(Continued)
- 21 -

Product warranties

 

The provision for product warranties relates to expected warranty claims on products sold in the last two years. It is expected that the majority of this expenditure will be incurred in the next financial year and that all will be incurred within two years of the balance sheet date

16
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Assets
Assets
2024
2023
Balances:
£
£
Accelerated capital allowances
76,406
76,406
There were no deferred tax movements in the year.

The deferred tax liability set out above is expected to reverse after 12 months and relates to accelerated capital allowances that are expected to mature within the same period. A potential deferred tax asset of £617k (2023: £699k) relating to trading losses has not been recognised as a result of the uncertainty as to its future recoverability.

17
Deferred income
2024
2023
£
£
Other deferred income
606,595
628,912
Included in the financial statements as follows:
Current liabilities
560,167
491,664
Non-current liabilities
46,428
137,248
606,595
628,912
18
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
158,183
176,360

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund. At 31 December 2024, the company owes £19,500 (2023: £29,323).

AUTOLOGIC DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
19
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
509,300
509,300
5,093
5,093
A ordinary shares of 1p each
400,501
400,501
4,005
4,005
B ordinary shares of 1p each
150,000
150,000
1,500
1,500
C ordinary shares of 1p each
150,000
150,000
1,500
1,500
1,209,801
1,209,801
12,098
12,098

All of the above shares rank pari passu except the B and C shares which have no voting rights.

20
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
64,981
120,483
Between two and five years
45,030
15,138
110,011
135,621
21
Related party transactions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 not to disclose related party transactions with wholly owned subsidiaries within the group.

During the year, companies under common directorship received £110,348 (2023: £548) in expenses and directors fees. At 31 December 2024, the companies were owed £0 (2023: £0) by Autologic Diagnostics Ltd.

22
Ultimate controlling party

The company is a wholly owned subsidiary of Autologic Diagnostics Holdings Limited, Unit 7 Wornal Park, Menmarsh Road, Worminghall, Buckinghamshire, HP18 9PH (company number 07079844).

The ultimate parent company is Ograi TopCo AB, a company registered in Sweden (559226-3098). Ograi TopCo AB is the smallest and largest parent undertaking for which Group financial statements are drawn up and of which the Company is a member. Copies of Ograi TopCo AB Financial statements can be obtained from: Opus Group, Ostra Hamngatan 16, 411 09 Gothenburg, Sweden.

2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.100Mr J L BrandtMr K J FinnMr L GeilenMr B Herron068141802024-01-012024-12-3106814180bus:Director12024-01-012024-12-3106814180bus:Director22024-01-012024-12-3106814180bus:Director32024-01-012024-12-3106814180bus:Director42024-01-012024-12-3106814180bus:RegisteredOffice2024-01-012024-12-31068141802024-12-31068141802023-01-012023-12-3106814180core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3106814180core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31068141802023-12-3106814180core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3106814180core:FurnitureFittings2024-12-3106814180core:ComputerEquipment2024-12-3106814180core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3106814180core:FurnitureFittings2023-12-3106814180core:ComputerEquipment2023-12-3106814180core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3106814180core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3106814180core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3106814180core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3106814180core:CurrentFinancialInstruments2024-12-3106814180core:CurrentFinancialInstruments2023-12-31068141802023-12-3106814180core:ShareCapital2024-12-3106814180core:ShareCapital2023-12-3106814180core:SharePremium2024-12-3106814180core:SharePremium2023-12-3106814180core:RetainedEarningsAccumulatedLosses2024-12-3106814180core:RetainedEarningsAccumulatedLosses2023-12-3106814180core:ShareCapital2022-12-3106814180core:SharePremium2022-12-3106814180core:RetainedEarningsAccumulatedLosses2022-12-3106814180core:ShareCapitalOrdinaryShareClass12024-12-3106814180core:ShareCapitalOrdinaryShareClass12023-12-3106814180core:ShareCapitalOrdinaryShareClass22024-12-3106814180core:ShareCapitalOrdinaryShareClass22023-12-3106814180core:ShareCapitalOrdinaryShareClass32024-12-3106814180core:ShareCapitalOrdinaryShareClass32023-12-3106814180core:ShareCapitalOrdinaryShareClass42024-12-3106814180core:ShareCapitalOrdinaryShareClass42023-12-3106814180core:ShareCapitalOrdinaryShares2024-12-3106814180core:ShareCapitalOrdinaryShares2023-12-3106814180core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3106814180core:FurnitureFittings2024-01-012024-12-3106814180core:ComputerEquipment2024-01-012024-12-3106814180core:UKTax2024-01-012024-12-3106814180core:UKTax2023-01-012023-12-310681418012024-01-012024-12-310681418012023-01-012023-12-310681418022024-01-012024-12-310681418022023-01-012023-12-3106814180core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3106814180core:FurnitureFittings2023-12-3106814180core:ComputerEquipment2023-12-3106814180core:Non-currentFinancialInstruments2024-12-3106814180core:Non-currentFinancialInstruments2023-12-3106814180core:Subsidiary12024-01-012024-12-3106814180core:Subsidiary22024-01-012024-12-3106814180core:Subsidiary32024-01-012024-12-3106814180core:Subsidiary42024-01-012024-12-3106814180core:Subsidiary112024-01-012024-12-3106814180core:Subsidiary222024-01-012024-12-3106814180core:Subsidiary332024-01-012024-12-3106814180core:Subsidiary442024-01-012024-12-3106814180bus:OrdinaryShareClass12024-01-012024-12-3106814180bus:OrdinaryShareClass22024-01-012024-12-3106814180bus:OrdinaryShareClass32024-01-012024-12-3106814180bus:OrdinaryShareClass42024-01-012024-12-3106814180bus:OrdinaryShareClass12024-12-3106814180bus:OrdinaryShareClass12023-12-3106814180bus:OrdinaryShareClass22024-12-3106814180bus:OrdinaryShareClass22023-12-3106814180bus:OrdinaryShareClass32024-12-3106814180bus:OrdinaryShareClass32023-12-3106814180bus:OrdinaryShareClass42024-12-3106814180bus:OrdinaryShareClass42023-12-3106814180bus:AllOrdinaryShares2024-12-3106814180bus:AllOrdinaryShares2023-12-3106814180core:WithinOneYear2024-12-3106814180core:WithinOneYear2023-12-3106814180core:BetweenTwoFiveYears2024-12-3106814180core:BetweenTwoFiveYears2023-12-3106814180bus:PrivateLimitedCompanyLtd2024-01-012024-12-3106814180bus:FRS1022024-01-012024-12-3106814180bus:Audited2024-01-012024-12-3106814180bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP